Historically, hop cones (Humulus lupulus) have been used since ancient times as a remedy for many ailments and, as a source of polyphenols and bitter acids, is very effective in the treatment of metabolic syndrome (MS). Hop flavonoids, particularly xanthohumol (XN), are substances with hypoglycemic, antihyperlipidemic, and antiobesity activities. Iso-α-acids (IAA) and matured hop bitter acids (MHBA) improve health by influencing lipid metabolism, glucose tolerance, and body weight. The modulatory effect of IAA and MHBA on lipid metabolism may also be responsible for a loss in body weight. These results suggest promising applications for IAA, MHBA, and XN in humans, particularly in the prevention of diet-induced obesity and diabetes.

Department of Biotechnology University of Chemistry and Technology Prague Technická 5 166 28 Prague 6 Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc18024548

003      

CZ-PrNML

005      

20180710095250.0

007      

ta

008      

180709s2017 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3390/molecules22101761 $2 doi

035    __

$a (PubMed)29048380

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Dostálek, Pavel $u Department of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic. Pavel.Dostalek@vscht.cz.

245    10

$a Hop Phytochemicals and Their Potential Role in Metabolic Syndrome Prevention and Therapy / $c P. Dostálek, M. Karabín, L. Jelínek,

520    9_

$a Historically, hop cones (Humulus lupulus) have been used since ancient times as a remedy for many ailments and, as a source of polyphenols and bitter acids, is very effective in the treatment of metabolic syndrome (MS). Hop flavonoids, particularly xanthohumol (XN), are substances with hypoglycemic, antihyperlipidemic, and antiobesity activities. Iso-α-acids (IAA) and matured hop bitter acids (MHBA) improve health by influencing lipid metabolism, glucose tolerance, and body weight. The modulatory effect of IAA and MHBA on lipid metabolism may also be responsible for a loss in body weight. These results suggest promising applications for IAA, MHBA, and XN in humans, particularly in the prevention of diet-induced obesity and diabetes.

650    _2

$a tělesná hmotnost $x účinky léků $7 D001835

650    _2

$a flavonoidy $x chemie $x farmakologie $x terapeutické užití $7 D005419

650    _2

$a glukózový toleranční test $7 D005951

650    _2

$a lidé $7 D006801

650    _2

$a Humulus $x chemie $7 D027582

650    _2

$a metabolismus lipidů $x účinky léků $7 D050356

650    _2

$a metabolický syndrom $x farmakoterapie $x prevence a kontrola $7 D024821

650    _2

$a molekulární struktura $7 D015394

650    _2

$a fytonutrienty $x chemie $x farmakologie $x terapeutické užití $7 D064209

650    _2

$a propiofenony $x farmakologie $x terapeutické užití $7 D011427

655    _2

$a časopisecké články $7 D016428

655    _2

$a přehledy $7 D016454

700    1_

$a Karabín, Marcel $u Department of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic. Marcel.Karabin@vscht.cz.

700    1_

$a Jelínek, Lukáš $u Department of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic. Lukas.Jelinek@vscht.cz.

773    0_

$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 22, č. 10 (2017)

856    41

$u https://pubmed.ncbi.nlm.nih.gov/29048380 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20180709 $b ABA008

991    __

$a 20180710095540 $b ABA008

999    __

$a ok $b bmc $g 1316679 $s 1021469

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2017 $b 22 $c 10 $e 20171019 $i 1420-3049 $m Molecules $n Molecules $x MED00180394

LZP    __

$a Pubmed-20180709